- Home
- DAVA vs LFCR Comparison
DAVA vs LFCR Comparison
Compare DAVA & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DAVA | LFCR |
|---|---|---|
| Founded | 2000 | 1986 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 170.2M | 143.9M |
| IPO Year | 2015 | 1996 |
Fundamental Metrics
Financial Performance| Metric | DAVA | LFCR |
|---|---|---|
| Price | $2.88 | $5.36 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 3 |
| Target Price | ★ $13.50 | $6.00 |
| AVG Volume (30 Days) | ★ 451.0K | 175.7K |
| Earning Date | 05-19-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $557,559,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $4.07 | $5.04 |
| P/E Ratio | $20.02 | ★ N/A |
| Revenue Growth | N/A | ★ 6.36 |
| 52 Week Low | $2.67 | $3.63 |
| 52 Week High | $16.05 | $8.98 |
Technical Indicators
Market Signals| Indicator | DAVA | LFCR |
|---|---|---|
| Relative Strength Index (RSI) | 36.74 | 53.31 |
| Support Level | N/A | $4.75 |
| Resistance Level | $3.58 | $5.92 |
| Average True Range (ATR) | 0.18 | 0.31 |
| MACD | 0.02 | 0.01 |
| Stochastic Oscillator | 24.78 | 52.08 |
Price Performance
Historical ComparisonAbout DAVA Endava plc (each representing one)
Endava is a next-generation IT services company that primarily assists clients with their digital transformation efforts by creating customized software for them. The company was founded in 2006 in the UK, and it continues to generate the majority of revenue in the UK and Europe. Endava's client base is concentrated in the payments and financial services, technology, media, and telecom industries.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.